This patient group direction (PGD) template supports the administration of HepA/Typhoid vaccine to individuals considered at risk of exposure to Salmonella enterica serovar typhi, (S. typhi) and/or hepatitis A virus, in accordance with recommendations from the National Travel Health Network and Centre (NaTHNaC) or in accordance with PHE hepatitis A temporary recommendations.
It is valid from 1 March 2018 to 29 February 2020.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).
Practitioners should follow local policy and procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, Green Book, and Summary of Product Characteristics for the vaccine.